Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MaZiRenWan for Functional Constipation
NCT01695850Phase 2Completed
- Sponsor
- Hong Kong Baptist University
- Start
- Jun 2013
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of mazirenwan in functional constipation (FC) (3 arms), sponsored by Hong Kong Baptist University. Primary endpoint: Responder rate for Complete Spontaneous Bowel Movement at 8 weeks. Started Jun 2013; status: completed.
02
Drugs
mazirenwan
03
Conditions
functional constipation (FC)
Beyond the preview
Go deeper on NCT01695850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01695850.